JB Chemicals Gets USFDA Nod for Generic Hypertension Drug
x
JB Chemicals receives USFDA approval to market a generic hypertension drug, Bisoprolol tablets, in strengths of 5 mg and 10 mg.
New Delhi, Apr 18 (PTI) JB Chemicals and Pharmaceuticals on Friday said it has received approval from the US health regulator to market a generic medication to treat high blood pressure.
The company has received approval from the US Food and Drug Administration (USFDA) for Bisoprolol tablets in strengths of 5 mg and 10 mg, the company said in a regulatory filing.
The company's product is the generic version of Teva's Zebeta tablets, which are indicated for the management of hypertension.
The company has received approval from the US Food and Drug Administration (USFDA) for Bisoprolol tablets in strengths of 5 mg and 10 mg, the company said in a regulatory filing.
The company's product is the generic version of Teva's Zebeta tablets, which are indicated for the management of hypertension.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 6.98 (+ 0.58)
- 66571563
- Standard Capital
- 0.39 ( -4.88)
- 61713587
- KBC Global
- 0.37 (+ 2.78)
- 53790157
- Murae Organisor
- 1.48 (+ 4.96)
- 34268132
- Harshil Agrotech
- 2.16 (+ 2.37)
- 32111948
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback